AADI BIOSCIENCE INC's ticker is and the CUSIP is 00032Q104. A total of 70 filers reported holding AADI BIOSCIENCE INC in Q1 2023. The put-call ratio across all filers is 2.17 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,733,499 | -28.4% | 771,384 | +1.2% | 0.00% | – |
| Q2 2023 | $5,211,424 | -6.7% | 761,904 | -1.3% | 0.00% | – |
| Q1 2023 | $5,587,296 | -41.1% | 771,726 | +4.5% | 0.00% | – |
| Q4 2022 | $9,478,046 | -9.5% | 738,741 | -0.3% | 0.00% | – |
| Q3 2022 | $10,473,000 | +1.9% | 741,169 | -11.1% | 0.00% | – |
| Q2 2022 | $10,273,000 | -20.4% | 833,827 | +9.7% | 0.00% | – |
| Q1 2022 | $12,902,000 | -29.8% | 760,283 | -0.2% | 0.00% | – |
| Q4 2021 | $18,389,000 | +429.3% | 761,473 | +543.8% | 0.00% | – |
| Q3 2021 | $3,474,000 | – | 118,277 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $193,062 | 17.76% |
| Alerce Investment Management, L.P. | 1,630,830 | $11,807,209 | 15.60% |
| ACUTA CAPITAL PARTNERS, LLC | 1,849,402 | $13,389,670 | 9.86% |
| Decheng Capital Management III (Cayman), LLC | 526,329 | $3,810,622 | 1.54% |
| Knott David M Jr | 183,688 | $1,330 | 0.52% |
| Vivo Capital, LLC | 509,572 | $6,456,277 | 0.45% |
| Ghost Tree Capital, LLC | 150,000 | $1,086,000 | 0.32% |
| Avoro Capital Advisors LLC | 2,849,402 | $20,629,670 | 0.31% |
| Parkman Healthcare Partners LLC | 75,961 | $549,958 | 0.12% |
| RA Capital Management | 590,218 | $4,273,178 | 0.10% |